GE stock rockets after $21 billion deal with Danaher, but remains below key chart level
February 25, 2019 at 11:50 AM EST
Shares of General Electric Co. rocket after a deal to sell the company’s biopharma business for $21.4 billion in cash to Danaher Corp, but remain on track to extend their longest streak below the widely watched 200-day moving average in at least 40 years.